Mr has made over 1 trades of the Syndax Pharmaceuticals Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 968 units of SNDX stock worth $16,117 on 1 February 2022.
The largest trade he's ever made was selling 968 units of Syndax Pharmaceuticals Inc stock on 1 February 2022 worth over $16,117. On average, Mr trades about 484 units every 0 days since 2022.
You can see the complete history of Mr Nolte stock trades at the bottom of the page.
Alexander Nolte is the Interim Principal Financial Officer, VP & Chief Accounting Officer at Syndax Pharmaceuticals Inc.
Mr Nolte is 49, he's been the Interim Principal Financial Officer and VP & Chief Accounting Officer of Syndax Pharmaceuticals Inc since . There are 12 older and 3 younger executives at Syndax Pharmaceuticals Inc. The oldest executive at Syndax Pharmaceuticals Inc is Dr. Michael L. Meyers M.D., Ph.D., 70, who is the Chief Medical Officer & Sr. VP.
Alexander's mailing address filed with the SEC is C/O SYNDAX PHARMACEUTICALS, INC., 35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3, WALTHAM, MA, 02451.
Over the last 9 years, insiders at Syndax Pharmaceuticals Inc have traded over $1,950,406 worth of Syndax Pharmaceuticals Inc stock and bought 210,921 units worth $2,347,816 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Luke Evnin, and Briggs Morrison. On average, Syndax Pharmaceuticals Inc executives and independent directors trade stock every 50 days with the average trade being worth of $745,679. The most recent stock trade was executed by Keith A. Goldan on 14 June 2024, trading 1,250 units of SNDX stock currently worth $25,038.
syndax pharmaceuticals is a biotechnology company located at 35 gatehouse dr., building d, floor 3, waltham, ma 02451.
Syndax Pharmaceuticals Inc executives and other stock owners filed with the SEC include: